FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula 10 and method for production thereof. Compounds possess properties of receptor tyrosine kinase type I inhibitors and can be used in treating hyperproliferative disorders. Invention also relates to novel intermediate compounds of formula 8 and 9 and to method of producing compounds 9. Compounds 10 and 8 correspond to common formulas (8) (10), where each R6, R8 and R8a are independently hydrogen or C1-C6alkyl, where said alkyl is optionally substituted OR15; or R8 and R8a together with atom to which they are connected, three-six-Member carbocyclic ring is formed; and R15 is hydrogen or C1-C6alkyl. Connection 9 corresponds to general formula (9), where A represents O; E represents , where X is CH; D1, D2 and D3 independently represent N or CR19; D4 and D5 are independently N or CR19 and D6 represents O, S or NR20, at least one of D4 and D5 is not CR19; D7, D8, D9 and D10 represent independently N or CR19, wherein at least one of D7, D8, D9 and D10 represents N; R1 represents H or C1-C6alkyl; each R2 independently represents halogen, cyano, trifluoromethyl, difluoromethyl, ftormetil or C1-C6alkyl; each R6, R8 and R8a are independently hydrogen or C1-C6alkyl, where said alkyl is optionally substituted by OR15, or R8 and R8a together with atom, to which they are bonded, 3-6-member carbocyclic ring is formed; R15 represents H or C1-C6alkyl; each R19 independently represents H, halogen or C1-C6alkyl; each R20 is independently hydrogen or C1-C4alkyl, j is 0 and n represents 0, 1 or 2.
EFFECT: method of preparing compound of formula 10 involves condensation of compound of formula 8 with compound of formula 2 (2) in presence of acid in acceptable solvent, followed by thiourea of formula 9 cyclization, preferably in water solution of NaOH in tetrahydrofuran with addition of thozilchloride TsCl.
9 cl, 1 tbl, 281 ex
Title | Year | Author | Number |
---|---|---|---|
N4-PHENYLQUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS RECEPTOR TYROSINE KINASE TYPE ERBB INIHIBITORS FOR TREATING HYPERPROLIFERATIVE DISEASES | 2006 |
|
RU2428421C2 |
SUBSTITUTED PIRIDAZINE-CARBOXAMIDE COMPOUNDS AS KINASE-INHIBITING COMPOUNDS | 2009 |
|
RU2526618C2 |
QUINAZOLINE DERIVATIVES | 2004 |
|
RU2356896C2 |
PYRIMIDINE DERIVATIVES AS INHIBITORS OF PD1/PD-L1 ACTIVATION | 2018 |
|
RU2783211C2 |
DERIVATIVES OF PYRROLOPYRIMIDINE USEFUL AS JAK-KINASES INHIBITORS | 2012 |
|
RU2618673C2 |
METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED TETRAHYDROBENZOTHIEPINE OXIDES | 1998 |
|
RU2236406C2 |
JAK KINASE-MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF APPLYING THEREOF | 2010 |
|
RU2529019C2 |
HYDROXAMATE DERIVATIVES SUITABLE AS DEACETYLASE INHIBITORS | 2001 |
|
RU2302408C2 |
SPIROHETEROCYCLIC COMPOUNDS AND USE THEREOF AS THERAPEUTIC AGENTS | 2006 |
|
RU2428424C2 |
IMIDZOL DERIVATIVE CONDENSED HETEROCYCLE HAVING ACTIVE AMPK EFFECT | 2011 |
|
RU2635662C2 |
Authors
Dates
2016-07-27—Published
2006-11-15—Filed